Amidst a backdrop of volatile global markets, with U.S. stocks experiencing fluctuations driven by AI competition fears and mixed corporate earnings, investors are increasingly seeking stability ...
Roche’s Susvimo receives US FDA approval for the treatment of diabetic macular edema: Basel Thursday, February 6, 2025, 11:00 Hrs [IST] Roche announced that the US Food and Drug ...